Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 69501-69550 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05618353
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
PHASE4
Recruiting
700 participants
Started: Aug 21, 2023 · Completed: Apr 30, 2029
1 condition
2 sponsors
6 locations
NCT06677489
CKD-Heart: Heart Failure Prediction in Asian CKD Patients
N/A
Active, not recruiting
1,000 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06293222
Patient and Public Involvement and Engagement in Research With Children and Young People With Sickle Cell Disorder and Their Families
N/A
Active, not recruiting
20 participants
Started: Aug 21, 2023 · Completed: Apr 30, 2024
1 condition
2 sponsors
1 location
NCT05928767
Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.
N/A
Recruiting
200 participants
Started: Aug 21, 2023 · Completed: Dec 1, 2025
2 conditions
2 sponsors
4 locations
NCT05991310
Evaluating the Safety and Efficacy of Telemedicine Neurology Assessments on a Mobile Stroke Unit
NA
Active, not recruiting
270 participants
Started: Aug 21, 2023 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT06237439
Sharing HaRT in New Expanses
NA
Recruiting
302 participants
Started: Aug 21, 2023 · Completed: May 31, 2025
3 conditions
2 sponsors
1 location
NCT05873244
CXD101 in Immunotherapy-related Liver Cancer
PHASE2
Recruiting
44 participants
Started: Aug 21, 2023 · Completed: Dec 30, 2027
1 condition
1 sponsor
2 locations
NCT05597345
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
PHASE2
Recruiting
15 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05872854
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light
PHASE2
Active, not recruiting
20 participants
Started: Aug 21, 2023 · Completed: Dec 15, 2025
2 conditions
2 sponsors
1 location
NCT05975671
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
NA
Recruiting
52,500 participants
Started: Aug 21, 2023 · Completed: May 31, 2026
7 conditions
6 sponsors
4 locations
NCT05746884
Haemostatic Gel Prophylaxis for Post Duodenal Endoscopic Resection Bleeding
NA
Recruiting
234 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05999630
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated with Radioactive Iodine for Thyroid Cancer
PHASE3
Recruiting
100 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05874414
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
PHASE1/PHASE2
Recruiting
74 participants
Started: Aug 21, 2023 · Completed: Oct 31, 2026
1 condition
1 sponsor
9 locations
NCT06282419
The Effect of Visual and Audio Stimulus Offered to Father-to-be
NA
Recruiting
132 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06140251
Investigation of Biomarker Response to SGLT2 Inhibition in Heart Failure
N/A
Recruiting
68 participants
Started: Aug 21, 2023 · Completed: May 1, 2025
1 condition
2 sponsors
1 location
NCT05887440
Isokinetic Strength Training in Hemiparetic Patient With Knee Extension Thrust
NA
Recruiting
12 participants
Started: Aug 21, 2023 · Completed: Dec 1, 2026
2 conditions
1 sponsor
1 location
NCT05488509
Acute Effects of Cannabis on Everyday Life Memory
PHASE2
Recruiting
156 participants
Started: Aug 21, 2023 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05939076
First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation
PHASE3
Not yet recruiting
220 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2028
1 condition
5 sponsors
6 locations
NCT05960331
Influence of Autonomy on Motor Learning in People With Parkinson's Disease
NA
Recruiting
72 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05989269
Diagnostic Stewardship for Ventilator Associated Pneumonia
NA
Active, not recruiting
400 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2025
1 condition
5 sponsors
3 locations
NCT06006624
Exparel vs Block for ACL Reconstruction
PHASE4
Enrolling by invitation
154 participants
Started: Aug 21, 2023 · Completed: Oct 30, 2024
2 conditions
1 sponsor
1 location
NCT06056648
Addressing Inequity in Dermatology
N/A
Recruiting
200 participants
Started: Aug 21, 2023 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT06167993
Complex Decongestive Physiotherapy Applied After Lymphovenous Anastomosis Surgery
NA
Recruiting
26 participants
Started: Aug 21, 2023 · Completed: Jun 15, 2024
2 conditions
1 sponsor
2 locations
NCT06110676
A Study to Evaluate the Efficacy and Safety of LZM012
PHASE3
Recruiting
918 participants
Started: Aug 21, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05774704
Curcumin and Retinal Study
PHASE1/PHASE2
Recruiting
60 participants
Started: Aug 21, 2023 · Completed: Mar 31, 2025
3 conditions
1 sponsor
1 location
NCT05862649
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
NA
Recruiting
300 participants
Started: Aug 21, 2023 · Completed: Nov 15, 2025
1 condition
2 sponsors
5 locations
NCT06174402
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
PHASE2/PHASE3
Recruiting
184 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
10 locations
NCT06113055
Hereditary Sensory Neuropathy Serine Trial
PHASE2
Recruiting
50 participants
Started: Aug 21, 2023 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05058157
Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae
NA
Active, not recruiting
20 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05843370
Modification of Ambient Air Pollution Exposure and Cardiopulmonary Outcomes by Socioeconomic Status and Nutrition
N/A
Enrolling by invitation
82 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT06136065
68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors
PHASE2
Recruiting
100 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2025
1 condition
1 sponsor
2 locations
NCT05698199
Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)
PHASE1
Active, not recruiting
10 participants
Started: Aug 21, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06037902
CPAP for Esophageal Cancer With Radiotherapy
NA
Recruiting
44 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06108453
A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Methotrexate in Elderly Subjects
PHASE1
Enrolling by invitation
10 participants
Started: Aug 21, 2023 · Completed: Nov 24, 2024
1 condition
1 sponsor
1 location
NCT05477082
Blood Biomarkers in Pediatric Kidney Transplant Recipients
N/A
Recruiting
30 participants
Started: Aug 21, 2023 · Completed: Nov 1, 2026
1 condition
1 sponsor
1 location
NCT05961124
Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer
PHASE2
Recruiting
40 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2027
4 conditions
2 sponsors
1 location
NCT06355934
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
N/A
Recruiting
55,000 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2026
1 condition
1 sponsor
26 locations
NCT06541860
DAratumumab and REvlimid REfractory MM
N/A
Recruiting
100 participants
Started: Aug 21, 2023 · Completed: Aug 21, 2028
1 condition
1 sponsor
1 location
NCT06013488
Character-Strengths Based Coaching For Work-Stress Reduction For Health Workers
NA
Recruiting
330 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT04251702
Biomarkers of Uterine Muscle Physiology
N/A
Recruiting
46 participants
Started: Aug 21, 2023 · Completed: Jul 31, 2024
2 conditions
3 sponsors
1 location
NCT06143371
A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.
PHASE1
Recruiting
80 participants
Started: Aug 21, 2023 · Completed: Apr 24, 2025
2 conditions
1 sponsor
1 location
NCT05935098
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
PHASE1
Active, not recruiting
263 participants
Started: Aug 21, 2023 · Completed: Mar 31, 2027
3 conditions
1 sponsor
26 locations
NCT05864118
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
NA
Recruiting
1,000 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05845866
Targeting Weight and Shape Concern Among Women with High Body Weight
NA
Active, not recruiting
60 participants
Started: Aug 21, 2023 · Completed: Aug 31, 2025
3 conditions
2 sponsors
1 location
NCT05983302
Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care
PHASE2/PHASE3
Recruiting
40 participants
Started: Aug 20, 2023 · Completed: Mar 20, 2024
1 condition
2 sponsors
2 locations
NCT05986136
Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
PHASE2/PHASE3
Recruiting
50 participants
Started: Aug 20, 2023 · Completed: Jul 20, 2028
1 condition
1 sponsor
1 location
NCT05829317
Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
PHASE4
Recruiting
200 participants
Started: Aug 20, 2023 · Completed: Jul 1, 2028
2 conditions
3 sponsors
4 locations
NCT06714812
Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib
N/A
Active, not recruiting
100 participants
Started: Aug 20, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05999149
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
PHASE3
Recruiting
424 participants
Started: Aug 20, 2023 · Completed: Aug 30, 2027
1 condition
1 sponsor
2 locations
NCT06010472
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
EARLY_PHASE1
Recruiting
36 participants
Started: Aug 20, 2023 · Completed: Aug 25, 2027
1 condition
2 sponsors
1 location
Previous
1
More pages
1388
1389
1390
1391
1392
1393
1394
More pages
2369
Next